International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ.
Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.
PMID:36422706
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH, Wan CL, Dai HP, Xue SL.
Ann Hematol. 2023 Aug;102(8):2001-2013. doi: 10.1007/s00277-023-05286-3. Epub 2023 May 25.
PMID:37227492
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma.
Hughes AD, Pölönen P, Teachey DT.
Haematologica. 2025 Sep 1;110(9):1934-1950. doi: 10.3324/haematol.2024.285643. Epub 2025 Jan 9.
PMID:39781622
T-lymphoblastic leukemia/lymphoma.
You MJ, Medeiros LJ, Hsi ED.
Am J Clin Pathol. 2015 Sep;144(3):411-22. doi: 10.1309/AJCPMF03LVSBLHPJ.
PMID:26276771
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA.